PRGO [NYSE]
Perrigo Company plc
Index- P/E- EPS (ttm)-1.01 Insider Own0.30% Shs Outstand134.00M Perf Week6.61%
Market Cap4.85B Forward P/E11.66 EPS next Y3.22 Insider Trans6.69% Shs Float133.94M Perf Month5.83%
Income-135.00M PEG- EPS next Q0.40 Inst Own98.10% Short Float6.25% Perf Quarter-0.56%
Sales4.20B P/S1.15 EPS this Y-401.70% Inst Trans3.24% Short Ratio5.30 Perf Half Y-12.07%
Book/sh38.09 P/B0.99 EPS next Y32.85% ROA-1.00% Target Price48.67 Perf Year-16.82%
Cash/sh15.24 P/C2.47 EPS next 5Y4.00% ROE-2.10% 52W Range31.32 - 50.90 Perf YTD-3.39%
Dividend1.04 P/FCF82.86 EPS past 5Y48.90% ROI0.20% 52W High-24.46% Beta0.98
Dividend %2.77% Quick Ratio3.00 Sales past 5Y-4.80% Gross Margin33.00% 52W Low22.77% ATR1.27
Employees9900 Current Ratio4.00 Sales Q/Q6.40% Oper. Margin9.10% RSI (14)66.49 Volatility4.03% 3.62%
OptionableYes Debt/Eq0.69 EPS Q/Q-146.60% Profit Margin-2.60% Rel Volume0.33 Prev Close37.58
ShortableYes LT Debt/Eq0.69 EarningsMay 11 BMO Payout- Avg Volume1.58M Price38.45
Recom- SMA2011.52% SMA506.43% SMA200-3.53% Volume39,174 Change2.32%
Oct-14-21Upgrade Raymond James Mkt Perform → Outperform $59
Sep-30-21Upgrade Jefferies Hold → Buy $45 → $63
Apr-07-21Resumed RBC Capital Mkts Sector Perform $51
Jan-06-21Downgrade RBC Capital Mkts Outperform → Sector Perform $59 → $49
Apr-17-20Downgrade Argus Buy → Hold
Mar-24-20Upgrade JP Morgan Neutral → Overweight $57
Mar-20-20Upgrade SVB Leerink Mkt Perform → Outperform $54 → $52
Mar-18-20Upgrade RBC Capital Mkts Sector Perform → Outperform $58
Oct-11-19Upgrade Argus Hold → Buy
Mar-20-19Initiated SunTrust Hold
Nov-13-18Downgrade Berenberg Buy → Hold
Aug-10-18Reiterated Stifel Hold $92 → $87
Jul-30-18Downgrade Argus Buy → Hold
Jul-12-18Downgrade Goldman Neutral → Sell
Jan-03-18Initiated Leerink Partners Mkt Perform $90
Dec-08-17Upgrade Argus Hold → Buy
Nov-10-17Upgrade RBC Capital Mkts Underperform → Sector Perform $64 → $86
Oct-05-17Reiterated UBS Buy $84 → $98
Sep-07-17Initiated Oppenheimer Outperform $88
Aug-11-17Upgrade Goldman Sell → Neutral
May-19-22 05:37PM  
08:43AM  
May-18-22 04:54PM  
May-17-22 03:38PM  
03:29PM  
May-13-22 01:26PM  
May-11-22 11:28AM  
09:47AM  
07:55AM  
06:53AM  
06:32AM  
06:21AM  
May-05-22 07:55PM  
08:36AM  
May-04-22 03:00PM  
May-02-22 07:30AM  
Apr-28-22 04:30PM  
Apr-27-22 09:03AM  
Apr-20-22 04:15PM  
Apr-04-22 07:30AM  
Mar-31-22 11:30AM  
Mar-29-22 01:49PM  
Mar-28-22 07:30AM  
Mar-24-22 04:22PM  
Mar-17-22 04:26PM  
Mar-10-22 08:22AM  
Mar-01-22 04:55PM  
10:18AM  
08:55AM  
07:46AM  
Feb-28-22 06:55PM  
10:00AM  
07:53AM  
Feb-25-22 08:16AM  
Feb-22-22 09:32AM  
Feb-21-22 09:40AM  
Feb-20-22 12:47AM  
Feb-16-22 12:30PM  
Feb-15-22 04:31PM  
12:00PM  
10:00AM  
09:40AM  
Feb-10-22 06:15PM  
Feb-09-22 05:45PM  
Feb-07-22 05:38PM  
09:38AM  
Feb-03-22 09:05AM  
Jan-31-22 12:24PM  
Jan-04-22 07:59AM  
Dec-28-21 12:38AM  
Dec-27-21 09:38PM  
09:38PM  
08:38PM  
07:38PM  
Dec-25-21 03:38PM  
06:38AM  
Dec-17-21 11:38PM  
Dec-15-21 06:38PM  
Dec-13-21 06:38PM  
06:38PM  
04:38PM  
04:38PM  
Dec-12-21 10:49PM  
Dec-11-21 06:38AM  
05:38AM  
03:38AM  
03:38AM  
Dec-10-21 01:38AM  
Dec-08-21 06:38PM  
04:38PM  
Dec-07-21 04:38PM  
04:38PM  
02:15PM  
Nov-29-21 11:32AM  
Nov-22-21 08:30AM  
Nov-10-21 01:00PM  
12:00PM  
10:15AM  
07:45AM  
07:18AM  
06:30AM  
06:27AM  
Nov-08-21 10:33AM  
08:30AM  
Nov-02-21 11:00AM  
Oct-27-21 03:03PM  
08:34AM  
Oct-18-21 04:12AM  
Oct-05-21 04:30PM  
Oct-01-21 04:44AM  
Sep-30-21 01:40PM  
12:09PM  
10:44AM  
09:36AM  
09:25AM  
09:01AM  
08:31AM  
07:43AM  
05:09AM  
Sep-29-21 07:32PM  
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals segments. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the brand names of Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, and Dr. Fresh. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 30 countries, primarily in Europe. The Prescription Pharmaceuticals segment develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, controlled substances, injectable, hormones, oral solid dosage forms, and oral liquid formulations in the United States, as well as pharmaceutical and diagnostic products in Israel. In addition, it offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Doyle Katherine C.DirectorMay 17Option Exercise38.576,599254,5239,530May 19 01:54 PM
Karaboutis AdrianaDirectorMay 17Option Exercise38.576,599254,52317,046May 19 01:55 PM
ASHFORD ORLANDO DDirectorMay 17Option Exercise38.576,599254,5238,150May 19 01:53 PM
Mann Erica LDirectorMay 17Option Exercise38.576,599254,52312,289May 19 01:53 PM
O'Connor DonalDirectorMay 17Option Exercise38.576,599254,52320,054May 19 01:54 PM
KINDLER JEFFREY BDirectorMay 17Option Exercise38.576,599254,52317,574May 19 01:52 PM
Parker Geoffrey M.DirectorMay 17Option Exercise38.576,599254,52314,829May 19 01:52 PM
Alford Bradley ADirectorMay 17Option Exercise38.576,599254,52330,577May 19 01:53 PM
Samuels Theodore R. IIDirectorMay 17Option Exercise38.576,599254,52326,693May 19 01:53 PM
SILCOCK RAYMONDEVP, Chief Financial OfficerApr 05Option Exercise36.273,963143,73860,955Apr 07 07:41 AM
Farrington ThomasEVP and CIOMar 14Sale37.232,25984,1030Mar 16 01:26 PM
Farrington ThomasEVP and CIOMar 14Sale37.1324,485909,0790Mar 16 01:26 PM
Janish Ronald CraigEVP, Gbl Ops & SC & CTOMar 07Sale36.733,954145,23215,686Mar 08 04:58 PM
ASHFORD ORLANDO DDirectorMar 04Option Exercise37.232,984111,0942,984Mar 08 04:56 PM
Farrington ThomasEVP and CIOMar 04Option Exercise37.234,424164,70625,185Mar 08 04:57 PM
SILCOCK RAYMONDEVP, Chief Financial OfficerMar 04Option Exercise37.238,502316,52958,796Mar 08 04:54 PM
KESSLER MURRAY SCEOMar 04Option Exercise37.2349,3281,836,481127,489Mar 08 04:55 PM
Quinn GrainneEVP, Chief Medical OfficerMar 04Option Exercise37.233,862143,78212,310Mar 08 04:55 PM
Dillard James E IIIEVP & President CSCAMar 04Option Exercise37.237,002260,68424,148Mar 08 04:56 PM
KINGMA TODD WExecutive VP, General CounselMar 04Option Exercise37.238,911331,75746,677Mar 08 04:56 PM
Andersen SvendEVP & President CHCIMar 04Option Exercise37.238,911331,75741,372Mar 08 04:54 PM
Janish Ronald CraigEVP, Gbl Ops & SC & CTOMar 04Option Exercise37.235,410201,41420,559Mar 08 04:58 PM
Willis RobertEVP & CHROMar 04Option Exercise37.235,012186,5979,760Mar 08 04:58 PM
Dillard James E IIIEVP & President CSCAFeb 07Option Exercise36.954,297158,77414,900Feb 09 11:32 AM
KINGMA TODD WExecutive VP, General CounselDec 17Buy37.553,000112,64851,856Dec 20 12:05 PM
Alford Bradley ADirectorDec 16Buy36.8813,000479,40923,978Dec 16 03:39 PM
Parker Geoffrey M.DirectorDec 16Buy36.855,000184,27010,879Dec 17 12:34 PM
Andersen SvendEVP & President CHCIDec 06Buy37.103,655135,59913,683Dec 07 11:12 AM
SILCOCK RAYMONDEVP, Chief Financial OfficerDec 03Buy36.0327,500990,93037,696Dec 06 08:31 AM
CLASSON ROLF ADirectorDec 02Buy35.672,80099,87417,442Dec 03 11:10 AM
Doyle Katherine C.DirectorAug 12Option Exercise41.285,637232,6955,637Aug 16 12:02 PM